BMJ sexual & reproductive health

BMJ Sex Reprod Health · ISSN (e) 2515-2009 · 5 papers in corpus
review 2024
doi:10.1136/bmjsrh-2024-202274 ·PMID:38857991

INTRODUCTION: Menstrual health is a key patient-reported outcome beyond its importance as a general indicator of health and fertility. However, menstrual function was not measured in the clinical trials of COVID-19 vaccines. The purpose of …

2024
doi:10.1136/bmjsrh-2023-202011 ·PMID:38862196

IntroductionIn June 2021, high-profile testimonials in the media about pain during intrauterine device (IUD) procedures in the UK prompted significant discussion across platforms including Twitter (subsequently renamed X). We examined a sam…

2023
review 2021
doi:10.1136/bmjsrh-2020-200619 ·PMID:32398290

INTRODUCTION: Progestogens (progestins) are widely used for contraception, in postmenopausal hormone therapy, and in treatment of abnormal uterine bleeding and endometriosis. Norethisterone (NET) and its acetate (NETA) differ from other pro…

2019
doi:10.1136/bmjsrh-2019-200395 ·PMID:31537614

Progress in developing new reversible male contraception has been slow. While the hormonal approach has been clearly shown to be capable of providing effective and reversible contraception, there remains no product available. Currently, tri…